abstract |
The invention is concerned with novel sulfonamide derivatives of formula (I) n n n n n n n n n n wherein R 2 , R 3 , R 4 , A, X, Y 1 , Y 2 , Y 3 , Y 4 and Z 1 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments. |